Nature Communications (Aug 2024)

Prefrontal cortex molecular clock modulates development of depression-like phenotype and rapid antidepressant response in mice

  • David H. Sarrazin,
  • Wilf Gardner,
  • Carole Marchese,
  • Martin Balzinger,
  • Chockalingam Ramanathan,
  • Marion Schott,
  • Stanislav Rozov,
  • Maxime Veleanu,
  • Stefan Vestring,
  • Claus Normann,
  • Tomi Rantamäki,
  • Benedicte Antoine,
  • Michel Barrot,
  • Etienne Challet,
  • Patrice Bourgin,
  • Tsvetan Serchov

DOI
https://doi.org/10.1038/s41467-024-51716-9
Journal volume & issue
Vol. 15, no. 1
pp. 1 – 17

Abstract

Read online

Abstract Depression is associated with dysregulated circadian rhythms, but the role of intrinsic clocks in mood-controlling brain regions remains poorly understood. We found increased circadian negative loop and decreased positive clock regulators expression in the medial prefrontal cortex (mPFC) of a mouse model of depression, and a subsequent clock countermodulation by the rapid antidepressant ketamine. Selective Bmal1KO in CaMK2a excitatory neurons revealed that the functional mPFC clock is an essential factor for the development of a depression-like phenotype and ketamine effects. Per2 silencing in mPFC produced antidepressant-like effects, while REV-ERB agonism enhanced the depression-like phenotype and suppressed ketamine action. Pharmacological potentiation of clock positive modulator ROR elicited antidepressant-like effects, upregulating plasticity protein Homer1a, synaptic AMPA receptors expression and plasticity-related slow wave activity specifically in the mPFC. Our data demonstrate a critical role for mPFC molecular clock in regulating depression-like behavior and the therapeutic potential of clock pharmacological manipulations influencing glutamatergic-dependent plasticity.